Verapamil

angiotensin I converting enzyme ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 19847946 Calcium channel blockers: monotherapy and dual therapy considerations in the treatment of hypertension. 2007 1
2 15106814 Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study. 2004 Jan 1
3 15167950 [Are all antihypertensive drugs renoprotective?]. 2004 May 1
4 11229627 Beneficial effect of verapamil added to chronic ACE inhibitor treatment on renal function in hypertensive elderly patients. 2000 2
5 11249535 The fixed combination of verapamil SR/trandolapril. 2000 Mar 1
6 9070551 Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group. 1997 Mar 15 2
7 9218197 Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertension. 1997 Mar 1
8 9218202 Requirements for antihypertensive therapy in diabetic patients: metabolic aspects. 1997 Mar 1
9 9218207 Angiotensin converting enzyme inhibitor-calcium antagonist combination: an alliance for cardioprotection? 1997 Mar 1
10 9313622 Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? 1997 Aug 1
11 7498985 Calcium channel blockers as inhibitors of angiotensin I-converting enzyme. 1995 Dec 1
12 7519695 Antihypertensive therapy and progression of diabetic renal disease. 1994 1
13 7512466 Stress response and antihypertensive treatment. 1993 2
14 8334915 Diabetic nephropathy. 1993 Aug 1
15 2670511 Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. 1989 Jul 1